Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning. McCurdy SR, Radojcic V, Tsai HL, Vulic A, et al. Blood 2022;139:608-623.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

McCurdy SR, Radojcic V, Tsai HL, Vulic A, et al. Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning. Blood 2022;139:608-623.
PMID: 34657151